Cargando…

Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017

This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consiste...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenwood, John, Hammarlund-Udenaes, Margareta, Jones, Hazel C., Stitt, Alan W., Vandenbrouke, Roosmarijn E., Romero, Ignacio A., Campbell, Matthew, Fricker, Gert, Brodin, Birger, Manninga, Heiko, Gaillard, Pieter J., Schwaninger, Markus, Webster, Carl, Wicher, Krzysztof B., Khrestchatisky, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674735/
https://www.ncbi.nlm.nih.gov/pubmed/29110676
http://dx.doi.org/10.1186/s12987-017-0079-9
_version_ 1783276838211026944
author Greenwood, John
Hammarlund-Udenaes, Margareta
Jones, Hazel C.
Stitt, Alan W.
Vandenbrouke, Roosmarijn E.
Romero, Ignacio A.
Campbell, Matthew
Fricker, Gert
Brodin, Birger
Manninga, Heiko
Gaillard, Pieter J.
Schwaninger, Markus
Webster, Carl
Wicher, Krzysztof B.
Khrestchatisky, Michel
author_facet Greenwood, John
Hammarlund-Udenaes, Margareta
Jones, Hazel C.
Stitt, Alan W.
Vandenbrouke, Roosmarijn E.
Romero, Ignacio A.
Campbell, Matthew
Fricker, Gert
Brodin, Birger
Manninga, Heiko
Gaillard, Pieter J.
Schwaninger, Markus
Webster, Carl
Wicher, Krzysztof B.
Khrestchatisky, Michel
author_sort Greenwood, John
collection PubMed
description This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers.
format Online
Article
Text
id pubmed-5674735
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-56747352017-11-15 Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017 Greenwood, John Hammarlund-Udenaes, Margareta Jones, Hazel C. Stitt, Alan W. Vandenbrouke, Roosmarijn E. Romero, Ignacio A. Campbell, Matthew Fricker, Gert Brodin, Birger Manninga, Heiko Gaillard, Pieter J. Schwaninger, Markus Webster, Carl Wicher, Krzysztof B. Khrestchatisky, Michel Fluids Barriers CNS Review This is a report on the CNS barrier congress held in London, UK, March 22–23rd 2017 and sponsored by Kisaco Research Ltd. The two 1-day sessions were chaired by John Greenwood and Margareta Hammarlund-Udenaes, respectively, and each session ended with a discussion led by the chair. Speakers consisted of invited academic researchers studying the brain barriers in relation to neurological diseases and industry researchers studying new methods to deliver therapeutics to treat neurological diseases. We include here brief reports from the speakers. BioMed Central 2017-11-07 /pmc/articles/PMC5674735/ /pubmed/29110676 http://dx.doi.org/10.1186/s12987-017-0079-9 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Greenwood, John
Hammarlund-Udenaes, Margareta
Jones, Hazel C.
Stitt, Alan W.
Vandenbrouke, Roosmarijn E.
Romero, Ignacio A.
Campbell, Matthew
Fricker, Gert
Brodin, Birger
Manninga, Heiko
Gaillard, Pieter J.
Schwaninger, Markus
Webster, Carl
Wicher, Krzysztof B.
Khrestchatisky, Michel
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_full Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_fullStr Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_full_unstemmed Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_short Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017
title_sort current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on cns barrier congress london, uk, 2017
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5674735/
https://www.ncbi.nlm.nih.gov/pubmed/29110676
http://dx.doi.org/10.1186/s12987-017-0079-9
work_keys_str_mv AT greenwoodjohn currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT hammarlundudenaesmargareta currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT joneshazelc currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT stittalanw currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT vandenbroukeroosmarijne currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT romeroignacioa currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT campbellmatthew currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT frickergert currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT brodinbirger currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT manningaheiko currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT gaillardpieterj currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT schwaningermarkus currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT webstercarl currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT wicherkrzysztofb currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017
AT khrestchatiskymichel currentresearchintobrainbarriersandthedeliveryoftherapeuticsforneurologicaldiseasesareportoncnsbarriercongresslondonuk2017